Vani Vannappagari, Ph.D.
Affiliations: | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
glioblastomaGoogle:
"Vani Vannappagari"Parents
Sign in to add mentorWilliam C. Miller | grad student | 2005 | UNC Chapel Hill | |
(Sexual risk behaviors, HIV knowledge and attitudes among a nationally representative sample of 14--49-year-old population of the Russian Federation.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Mocroft A, Pelchen-Matthews A, Hoy J, et al. (2023) Heavy arv exposure and exhausted/limited arv options: predictors and clinical outcomes. Aids (London, England) |
Sension MG, Brunet L, Hsu RK, et al. (2023) Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort. Infectious Diseases and Therapy |
Álvarez H, Mocroft A, Ryom L, et al. (2023) Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Hsu RK, Fusco JS, Henegar CE, et al. (2023) Heavily treatment-experienced people living with HIV in the OPERA® cohort: population characteristics and clinical outcomes. Bmc Infectious Diseases. 23: 91 |
Patel P, Ford SL, Baker M, et al. (2022) Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials. Hiv Medicine |
Mounzer KC, Fusco JS, Hsu RK, et al. (2021) Are We Hitting the Target? HIV Pre-Exposure Prophylaxis from 2012 to 2020 in the OPERA Cohort. Aids Patient Care and Stds |
Mounzer K, Brunet L, Hsu R, et al. (2021) Changes in BMI associated with antiretroviral regimen switch among treatment-experienced, virologically suppressed people living with HIV in the United States. Aids Research and Human Retroviruses |
Greenberg L, Ryom L, Neesgaard B, et al. (2020) Clinical outcomes of two-drug regimens vs. three-drug regimens in antiretroviral treatment-experienced people living with HIV. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America |
Ruderman SA, Crane HM, Nance RM, et al. (2020) Weight gain following antiretroviral therapy (ART) initiation in ART-naïve people living with HIV in the current treatment era. Journal of Acquired Immune Deficiency Syndromes (1999) |
Hsu R, Brunet L, Fusco JS, et al. (2020) Incident Type 2 diabetes mellitus after initiation of common HIV antiretroviral drugs. Aids (London, England) |